Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Morgan Stanley has ceased to be a substantial holder in Telix Pharmaceuticals Limited as of June 28, 2024, a change disclosed after their previous notification on May 21, 2024. The financial institution became aware of this status change on July 2, 2024, indicating a significant shift in investment stance regarding the pharmaceutical company.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
